Rallybio

Rallybio RLYB Stock

$15.47   -0.322166%
Add to favorites
Market Cap
$43.32M
LOW - HIGH [24H]
$15.15 - $15.70
VOLUME [24H]
$55.49K
P/E Ratio
1.67
Earnings per share
$9.22
ISIN
US75120L1008
Price   Prediction

Rallybio Price Chart

Sorry, that's all we've gotfor now...

Rallybio (RLYB) stock price today is 15.47 USD on Tech Market Small (-0.32% on the day). Updated .

Rallybio RLYB Financial and Trading Overview

Rallybio stock price 15.47 USD
Previous Close 15.52 USD
Open 15.32 USD
Bid 15.53 USD x 100
Ask 15.6 USD x 100
Day's Range 15.15 - 15.7 USD
52 Week Range 3.67 - 17.57 USD
Volume 50.49K USD
Avg. Volume 19.43K USD
Market Cap 86.63M USD
Beta (5Y Monthly) -0.768
PE Ratio (TTM) 1.6888647
EPS (TTM) 9.22 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est N/A

RLYB Valuation Measures

Enterprise Value -7403494 USD
Trailing P/E 1.6888647
Forward P/E -2.8648148
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 199.6129
Price/Book (mrq) 0.89390963
Enterprise Value/Revenue -17.059
Enterprise Value/EBITDA 0.338

Trading Information

Rallybio Stock Price History

Beta (5Y Monthly) -0.768
52-Week Change 209.40%
S&P500 52-Week Change 8.67%
52 Week High 17.57 USD
52 Week Low 3.67 USD
50-Day Moving Average 16.4 USD
200-Day Moving Average 13.66 USD

RLYB Share Statistics

Avg. Volume (3 month) 19.43K USD
Avg. Daily Volume (10-Days) 34.18K USD
Shares Outstanding 5.6M
Float 1.64M
Short Ratio 2.05
% Held by Insiders 27.10%
% Held by Institutions 76.07%
Shares Short 39.03K
Short % of Float 0.86%
Short % of Shares Outstanding 0.72%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:8

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 6177.41%
Operating Margin (ttm) -5050.92%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -16.78%
Return on Equity (ttm) 34.52%

Income Statement

Revenue (ttm) 434K USD
Revenue Per Share (ttm) 0.08 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) -5834000 USD
EBITDA -21913000 USD
Net Income Avi to Common (ttm) 26.81M USD
Diluted EPS (ttm) 9.16
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 90.69M USD
Total Cash Per Share (mrq) 16.85 USD
Total Debt (mrq) 0 USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 28.867
Book Value Per Share (mrq) 17.306

Cash Flow Statement

Operating Cash Flow (ttm) 30.99M USD
Levered Free Cash Flow (ttm) -9390625 USD

Profile of Rallybio

Country United States
State CT
City New Haven
Address 234 Church Street
ZIP 06510
Phone 203 859 3820
Website https://www.rallybio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 6

Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is the RLYB116, an inhibitor of complement component 5 (C5) to treat several diseases of complement dysregulation which has completed phase 1 trial; and RLYB332, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. The company has a strategic alliance with AbCellera to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases, as well as collaboration agreement with Johnson & Johnson to provide therapeutic solutions for pregnant individuals at risk of fetal and neonatal alloimmune thrombocytopenia. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.

Q&A For Rallybio Stock

What is a current RLYB stock price?

Rallybio RLYB stock price today per share is 15.47 USD.

How to purchase Rallybio stock?

You can buy RLYB shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Rallybio?

The stock symbol or ticker of Rallybio is RLYB.

Which industry does the Rallybio company belong to?

The Rallybio industry is Biotechnology.

How many shares does Rallybio have in circulation?

The max supply of Rallybio shares is 2.8M.

What is Rallybio Price to Earnings Ratio (PE Ratio)?

Rallybio PE Ratio is 1.67787420 now.

What was Rallybio earnings per share over the trailing 12 months (TTM)?

Rallybio EPS is 9.22 USD over the trailing 12 months.

Which sector does the Rallybio company belong to?

The Rallybio sector is Healthcare.

Rallybio RLYB included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 22617.73 USD —
-5.28
10.6B USD — 22513.01 USD — 23837.76 USD — — 10.6B USD —
us US Tech Global Select Market Com NQGS US 11139.01 USD —
-5.31
— — 11086.73 USD — 11742.47 USD — — — —
us US Tech Biotechnology NBI US 6781.89 USD —
-1.73
— — 6767.31 USD — 6980.47 USD — — — —
us US Tech Health Care IXHC US 1282.67 USD —
-1.79
— — 1279.99 USD — 1317.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.07T
Total marketcap
$55.69B
Total volume
BTC 58.82%   •   ETH 10.07%
Dominance
Select currency